Texas Capital Bank Wealth Management Services Inc bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 41,817 shares of the conglomerate's stock, valued at approximately $7,965,000.
A number of other institutional investors have also recently made changes to their positions in DHR. Sivia Capital Partners LLC grew its position in Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock worth $397,000 after purchasing an additional 119 shares during the period. First Trust Advisors LP lifted its holdings in shares of Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock valued at $10,947,000 after buying an additional 14,217 shares during the period. Main Street Financial Solutions LLC lifted its holdings in shares of Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock valued at $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC boosted its stake in shares of Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock worth $14,957,000 after buying an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC boosted its stake in shares of Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock worth $273,000 after buying an additional 325 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Danaher Stock Down 1.5%
NYSE DHR opened at $199.62 on Wednesday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market cap of $140.33 billion, a PE ratio of 35.46, a P/E/G ratio of 2.52 and a beta of 0.78. The stock's 50 day moving average is $193.74 and its 200 day moving average is $192.50.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company's revenue was up 5.5% on a year-over-year basis. During the same period last year, the firm posted $0.77 EPS. Research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Analyst Ratings Changes
DHR has been the subject of several research analyst reports. Evercore reaffirmed an "outperform" rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Guggenheim cut their price target on Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Jefferies Financial Group reaffirmed a "buy" rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Finally, UBS Group lowered their price objective on shares of Danaher from $270.00 to $250.00 and set a "buy" rating on the stock in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $228.91.
Get Our Latest Analysis on Danaher
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.